Kedudukan dalam Saham
#34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Harga Saham
$0.617
Disegerakkan terakhir: 2024-10-14
Perubahan (1 tahun)
0.00%
Perdagangan Kineta, Inc. (KA)
Harga KA dengan permodalan pasaran b
Modal pasaran bagi Kineta, Inc.(KA)
Modal Pasaran: $6.13M
Sehingga August 2026, Kineta, Inc. mempunyai modal pasaran sebanyak $6.13M. Ini menjadikan Kineta, Inc. syarikat ke-34153rd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Kineta, Inc. dari 2016 hingga 2026
KA berbanding dengan 5 teratas yang paling popular stocks
| Harga KA |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+88,899,769.10%
|
|
|
|
|
$4.490T
|
+73,215,580.36%
|
|
|
|
|
$4.162T
|
+67,873,417.34%
|
|
|
|
|
$3.676T
|
+59,947,495.51%
|
|
|
|
|
$2.833T
|
+46,196,383.65%
|
